Publications

Labib R, Bury D, Boisleve F, Eichenbaum G, Girard S, Naciff J, Leal M, Wong J. 2018. A kinetic-based safety assessment of consumer exposure to salicylic acid from cosmetic products demonstrates no evidence of a health risk from developmental toxicity. Regul Toxicol Pharmacol 94(Apr):245-251; doi: 10.1016/j.yrtph.2018.01.026. PMID: 29410076.

Renner G, Audebert F, Burfeindt J, Calvet B, Caratas-Perifan M, Leal ME, Gorni R, Long A, et al. 2017. Cosmetics Europe guidelines on the management of undesirable effects and reporting of serious undesirable effects from cosmetics in the European Union. Cosmetics 4(1):1; doi: 10.3390/cosmetics4010001.

Aguirre J I, Leal ME, Rivera MF, Vanegas SM, Jorgensen M, Wronski TJ. 2007. Effects of basic fibroblast growth factor and a prostaglandin E2 receptor subtype 4 agonist on osteoblastogenesis and adipogenesis in aged ovariectomized rats. J Bone Miner Res 22(6):877-88; doi: 10.1359/jbmr.070313. PMID: 17352655.